SUMMARY A recently presented hypothesis contends that the excess coronary heart disease mortality associated with hypertension is more prominent in lean men than in overweight men. This hypothesis was addressed using data collected in the Israeli Ischemic Heart Disease Study (n = 10,059). The ratios of age-adjusted 15-year death rates in hypertensive and normotensive men were 4.7,2.8,2.0, and 1.9 in the Quetelet index groups of <2.29,2.29 to 2.56,2.56 to 2.83 and >2.83 g/cm 2 , respectively. The corresponding ratios for all-cause mortality were 2.2,2.1,2.0, and 1.7, respectively. The group with the highest all-cause age-adjusted mortality, at 33.6%, was that of the leanest (<2.29 g/cm , bottom 20% of the Quetelet index distribution) hypertensive subjects. The same group also displayed the highest coronary heart disease mortality (age-adjusted rate, 18.2%). The findings persisted for both smokers and nonsmokers and after exclusion of men with coronary heart disease or diabetics at intake, men on antihypertensive medication, or those who died in the first 2 years of follow-up (1963-1965). A multivariate risk score for developing myocardial infarction was calculated, based on levels of age, systolic blood pressure, total cholesterol, high density lipoprotein cholesterol, cigarette smoking, diabetes mellitus, and Quetelet index. This score varied little across the four Quetelet index groups in hypertensive men: 5-year mean estimated risks of myocardial infarction were between 70 and 74/1000. In normotensive men the scores increased from 19/1000 in the leanest subjects to 29/1000 in the overweight ones. The overall trend of 15-year coronary heart disease mortality is thus in line with the multiple risk of 5-year myocardial infarction incidence, but the source of the risk differences between lean and overweight hypertensive subjects remains unclear. These findings may have important implications in making decisions regarding the mode of treatment, especially in the wide group of mildly hypertensive persons in whom the benefit of treatment is still controversial. The treating physician who wishes to make a therapeutic decision might need to consider low body weight as either inherently representing or associated with an unfavorable prognosis. (Hypertension 10: 22-28, 1987) KEY WORDS • hypertension • coronary heart disease • coronary risk factors • obesity T HE association of hypertension and obesity with cardiovascular risk has been explored in many epidemiological studies. High blood pressure has been identified as a major cardiovascular risk factor,' while the role of obesity in prediction of cardiovascular mortality remains controversial. Also
well established is the relationship between obesity and hypertension. 2 Subjects who experience weight gains are more prone to the development of hypertension than are persons who maintain normal or low weights. 3 Conversely, hypertensive (HT) persons have been reported to gain weight more readily. 4 Two recent investigations have focused on the interaction of hypertension, relative weight, and cardiovascular risk. 5 6 In both the California sample examined by Barrett-Connor and Khaw 5 and the French samples studied by Cambien et al. , 6 the role of blood pressure as a predictor of coronary heart disease (CHD) mortality was found to diminish with increasing body mass index. The hypothesis that emerged from these findings is that lean hypertensive men are particularly prone to CHD mortality. The present report used data from the Israeli Ischemic Heart Disease Study to examine this hypothesis.
Subjects and Methods
The cohort followed in the Israeli Ischemic Heart Disease Study for 15 years was composed of 10,059 tenured civil servants and municipal employees, aged 40 years and above. Various sampling fractions were employed within six subcontinents defined by the subjects' birthplaces to approach an ethnic distribution resembling that of the men in the total Israeli population at the time of the study. The initial examination of the subjects in 1963 included a physical examination, an electrocardiogram (12-lead), interviews for dietary and psychosocial information, and selected laboratory tests. Subsequent examinations were performed in 1965 and 1968. Descriptions of the population, methods, and examination procedures have appeared elsewhere. 7 -8 In all Israeli Ischemic Heart Disease Study examinees, blood pressure was measured in the recumbent position on the right arm, approximately 30 to 45 minutes after arrival at the center. A mercury sphygmomanometer standing on a bedside table at the same level as the subject's heart and an armband fitted with a standard 22 x 12-cm bladder and Velcro fastener were used. Systolic pressure was measured at the onset of the Korotkoff sounds, and diastolic pressure was measured at the point of disappearance of the sounds or of their muffling when they did not disappear. Blood pressure was then recorded on the examination sheet, and the physical examination was performed. At the end of the examination, and before blood-taking, blood pressure was measured a second time (approximately 15 minutes after the first reading), using the same method. The second measurement, considered to be closer to the near-basal pressure, was used in this analysis. The definition of hypertension in comparing mortality between HT and normotensive (NT) men was based on a diastolic blood pressure of 95 mm Hg or higher.
Included in the physical examinations were measurements of height and weight. Height was recorded to the nearest centimeter with the subject standing, without shoes. Weight was recorded to the nearest kilogram with the subject wearing trousers only. From these values, the Quetelet index (QI; weight in grams divided by height in centimeters squared) at entry was computed. 9 Fifteen-year mortality follow-up information was derived by matching identity card number with the Israeli Mortality Registry. The details of the 15-year follow-up study have been published. 10 The number of deaths identified over 15 years was 1664 (16.5%). In 618 of 1664 deaths identified (37.1%), the underlying cause of death was recorded as CHD.
For the purpose of this analysis, low weight and high weight subjects were defined as those in the bottom and top quantiles, corresponding to QI values of less than 2.29 g/cm 2 and more than 2.83 g/cm 2 , respectively. Death rates were compared in these quantiles as well as in the groups that were 30% below QI average (2.29-2.56 g/cm 2 ) and 30% above the average (2.56-2.83 g/cm 2 ). The rates presented in the tables were adjusted to the age structure of the total study population according to the age groups 40 to 49, 50 to 55, and 60 or more years.
Results

Total
and CHD mortality by QI categories for NT and HT men are presented in Table 1 . Although both total and CHD mortality were higher among HT than NT men in all the QI categories, the relative excess mortality in HT men was greater for the leaner subjects than for the overweight ones. This difference was pronounced in CHD mortality; relative HT/NT risks declined from 4.67 in the leanest quantile to 1.91 in the overweight quantile.
To ascertain whether the diminishing HT/NT mortality ratios were due to factors present at baseline and associated with both leanness and subsequent mortality, comparison of HT/NT mortality ratios was repeated excluding subjects with 1) CHD at baseline, 2) early first 2-year mortality, 3) known or newly identified diabetes or diabetes developing between 1963 and 1968. To correct for a possible interaction of cigarette smoking with relative weight and mortality, separate analyses were conducted for current cigarette smokers and for nonsmokers. The results are shown in Table 2 .
There were several changes with respect to total mortality. For nonsmokers as well as for subjects with no CHD in 1963, a gradient of total mortality HT/NT ratio was not evident. With respect to CHD mortality, however, when subjects with baseline CHD were excluded, the original trend of decreasing relative risks was maintained, with a relative risk of 3.79 among lean subjects dropping to 1.93 among the obese (see Table 2 ). Exclusion of subjects who experienced early mortality (within 2 years of baseline) did not alter the results, yielding relative risks of 4.99 and 1.98 for the leanest and heaviest groups, respectively (see Table  2 ). Although the trend of decreasing HT/NT relative risk was maintained for both cigarette smokers and nonsmokers, it appeared to be more prominent among the nonsmokers, indicating that cigarette smoking was not the cause for excess mortality in lean HT men. Exclusion of diabetics in 1963 and throughout the 5-year period 1963 to 1968 equally failed to alter the finding of increased risk among lean HT men (see Table 2 ).
Information on antihypertensive treatment was available in 1968, five years after follow-up began. Treatment was often initiated following the discovery of hypertension by the study examination and appears to have been highly ineffective, at least in the early period of the study. Death rate values are means ± SE. Hypertension NT = normotensive; HT = hypertensive; CHD = defined as diastolic blood pressure of 95 mm Hg or greater, coronary heart disease.
Quetelet index revealed similar patterns: the 21% death rate for the leanest HT decile fell to 13.9% in the top HT decile (Figure 1 ).
In an attempt to delineate factors that characterize the different QI and blood pressure categories, the mean values (or frequencies) of a number of biochemical, electrocardiographic, and behavioral variables were calculated (Table 3) . The results showed a decreasing difference of total serum cholesterol between HT and NT men as QI increased. This finding was mirrored by HT/NT differences in high density lipoprotein (HDL) cholesterol. Therefore, the HDL/total cholesterol ratio was similar in HT and NT men in all QI groups. Mean serum uric acid was notably reduced in NT men in the leanest group. Cigarette smoking was less prevalent in lean HT men than in lean NT men, but the same held true for overweight subjects. Expected HT/NT differences in the prevalence of left ventricular hypertrophy and ST-T electrocardiographic changes are evident in the data, as the rates of the measured electrocardiographic abnormalities are clearly elevated in HT men. As it is difficult to capture the HT/NT differences in a single index through the numerous comparisons of risk factor levels, we chose to use the 5-year risk of developing myocardial infarction as a summary measure. This estimated risk was calculated according to a previous analysis of the same data set," using a multiple logistic function that expressed the risk of myocardial infarction as a function of age, systolic blood pressure, total serum cholesterol, cigarette smoking, diabetes mellitus, HDL cholesterol, and QI. As shown in Table 3 , an equal risk of myocardial infarction was evident for all HT groups. In the lean NT group, however, the risk appeared low in comparison with the other three groups and the estimated HT/NT relative risk of developing myocardial infarction was somewhat elevated in the lean group. The latter relative risk equaled 3.8, which coincided with the observed relative long-term CHD mortality of subjects at risk for CHD (see Table 2 ).
Discussion
The findings reported in this study strongly support the hypothesis that the HT/NT ratio of CHD mortality declines with increasing relative body weight. BarrettConnor and Khaw, 5 in a 9-year mortality follow-up of 50-to 79-year-old men, demonstrated a significantly increased relative risk of CHD for low or average weight HT men but not for overweight ones. In our study the latter group still had increased mortality compared with overweight NT men, but the relative HT/NT risk of CHD death decreased with increasing QI.
The analysis by Cambien et al. 6 of cardiovascular mortality in two French samples demonstrated a trend of decreasing HT/NT relative risk of CHD death with increasing QI. Data collected in several other longterm mortality studies provide further evidence of the exceedingly high risk associated with the combination of leanness and hypertension. In the Evans County Study, analysis by blood pressure category and tertile CORONARY HEART DISEASE IN LEAN HYPERTENSIVE MEWGoldbourt et al. Hypertension defined as diastolic blood pressure of 95 mm Hg or greater. See Table 1 for key to abbreviations.
of corpulence showed a 3.8 relative risk for lean HT subjects as opposed to 1.5 in obese HT subjects.
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CHD rates among lean HT subjects in the Western Collaborative Group Study were 1.5 times those of overweight subjects. 13 Conversely, the Framingham Study showed that lean men had lower probability rates for CHD than did the obese ones at all levels of systolic blood pressure. 14 The pattern of decreased risk of CHD mortality with increased QI among HT men displayed in the Israeli Ischemic Heart Disease Study data was maintained when smokers, nonsmokers, subjects with CHD at baseline, and subjects who died within 2 years of baseline were each excluded from the analysis. Therefore, we cannot attribute the increased risk among lean HT men to smoking habits or to the presence of CHD or Subjects had not had a previous myocardial infarction, nor did they have definite angina, cancer HT = hypertensive; NT = normotensive; HDL = high density lipoprotein; C = cholesterol; Ml = myocardial infarction.
D E C I L E S O F Q U E T E L E T I N D E X
"Only two thirds of the population in this category were tested.
, hyperglycemia, or diabetes mellitus. LVH = left ventricular hypertrophy; malignant disease, associated with low weight caused by dieting or other reasons and exerting detrimental effects on the subjects, leading to early mortality. The trend was unaffected by exclusion of those on antihypertensive treatment in 1968. We also looked at four area-of-birth groups: Europe, Mideast, North Africa, and the mixed group of Israeli born. The data (not tabulated) indicate that the overall findings were maintained in the large European-born group of 5020 subjects (HT/NT ratios of 6.7, 2.1, 2.0, and 1.7 in the four QI groups, respectively), but not among the Mideastern-born. The numbers, however, in the latter group, and more so in the Israeli-born and the North Africanborn, were too small to obtain any meaningful estimate of lean HT mortality. The increased HT/NT ratio of CHD death rates for lean men observed in the present study appears to stem from both increased rates in HT men and reduced rates in NT men. Further investigation of the interaction between blood pressure and weight in determination of risk is needed to clarify the nature of this relationship. Differences in the estimated CHD risk profile between the Ql-hypertension categories might provide a partial explanation for the elevated HT/NT ratio of CHD death rates in the leanest groups, even though they do not precisely parallel the observed gradient. A similar analysis in some of the cohorts mentioned could illuminate a possible role of unfavorable CHD risk profiles for lean HT men in accounting for increased mortality in such persons. Among the explanations offered to account for the observed phenomenon is the opinion that lean HT men have been exposed to hypertension for a longer period than have overweight HT men, whose hypertension may have been a consequence of weight gain. 5 The increased prevalence of left ventricular hypertrophy in the lean HT group may support this explanation, although systematic screening for target organ damage was not performed. If this were true, the findings would imply more pronounced pathogenic effects of hypertension among those who have the longest exposure to the condition.
An additional possibility for the findings in this study is that hypertension in lean persons has different biological mechanisms than in the overweight and is therefore more harmful. Indeed, it has been suggested that persons with hypertension associated with obesity might be considered a special group. 1516 Various mechanisms have been suggested for hypertension associated with obesity: elevated cardiac output, increased body sodium resulting from hyperinsulinemia or abnormal aldosterone-renin relationship, and neuroendocrine abnormalities caused by increased noradrenergic activity or central opiate system suppression. 1516 Conversely, Mujais et al. 17 compared the hemodynamic and volume profiles of 50 obese HT men, 59 nonobese HT men, and 25 normal counterparts and found that the presence of moderate obesity did not alter the hemodynamic characteristics of established essential hypertension.
Our findings are unlikely to be affected by various levels of alcohol consumption among subjects, as alcohol consumption in Israel during the study period was extremely low 18 and was most likely even lower in a stable population of tenured, middle-aged, and elderly civil servants. Because alcohol was so scant no information was collected on its consumption in the study.
Spurious elevation of blood pressure in the obese patients 19 does not appear to explain the enhanced mortality of lean HT men. King 20 has indicated that in the severely obese, the use of a standard sphygmomanometer overestimated diastolic blood pressure by 8 mm Hg. We repeated our analysis with the diastolic blood pressure cutoff point for hypertension in the 20% most overweight subjects raised from 95 to 103 mm Hg. The ratio of death rates rose from 1.91 to 2.37, which remained clearly below that for the lean HT men (4.62). Some investigators have suggested that arm circumference is not important in increasing blood pressure. 21 One clinical application of these findings would be related to treatment in mild hypertension. In persons with mild hypertension, the decision to use nonpharmacological or pharmacological approaches is often based on whether other risk factors are present. The relative weight of a mildly HT person might be viewed in a new light when the present and similar findings are considered. Two questions come to mind: Since the low weight NT person appears to be so well guarded, do these findings imply that antihypertensive therapy in lean persons should be pursued more aggressively? Would it be justifiable to pursue weight reduction in HT persons as a universal policy?
In conclusion, strategies devised for combating hypertension in lean, middle-aged men may require an extensive evaluation. Similar studies in women should be encouraged.
